The association of bipolar spectrum disorders and borderline personality disorder

Psychiatric Quarterly

Volumn 83, Issue 4, 2012, Pages 449-465

  Antoniadis, Diomidis ^a,b   Samakouri, Maria ^a   Livaditis, Miltos ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b NONE   (Greece)

Author keywords

Bipolar Disorder; Borderline Personality Disorder; Genetics; Neuroanatomy; Neurochemistry

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; LAMOTRIGINE; LITHIUM; MOOD STABILIZER; VALPROIC ACID;

AMYGDALOID NUCLEUS; BIPOLAR DISORDER; BORDERLINE STATE; CLINICAL ASSESSMENT; CLINICAL FEATURE; DISEASE ASSOCIATION; DOPAMINERGIC ACTIVITY; DOPAMINERGIC SYSTEM; DSM-5; GENETICS; HUMAN; IMPULSIVENESS; LIMBIC SYSTEM; MENTAL INSTABILITY; NEUROANATOMY; NEUROCHEMISTRY; PROGNOSIS; PSYCHOTHERAPY; REVIEW; SEROTONINERGIC SYSTEM; SYMPTOMATOLOGY; SYSTEMATIC REVIEW;

EID: 84874114091     PISSN: 00332720     EISSN: 15736709     Source Type: Journal    
DOI: 10.1007/s11126-012-9214-6     Document Type: Review

References (144)

1. Millon T: Disorders of Personality: DSM-IV-TM and Beyond. New York, Wiley, 1996
2. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 3rd edn. Washington, DC, American Psychiatric Press, 1980
3. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington DC, American Psychiatric Press, 2000
4. Paris J, Gunderson J, Weinberg I: The interface between borderline personality disorder and bipolar spectrum disorders. Comprehensive Psychiatry 48:145-154, 2007
5. Ketter TA: Diagnostic features, prevalence, and impact of bipolar disorder. Journal of Clinical Psychiatry 71:e14, 2010
6. Semple D, Smyth R, Burns J, Darjee R, McIntosh A: Oxford Handbook of Psychiatry. New York, Oxford University Press, 2005
7. Merikangas KR, Akiskal HS, Angst J, Greenberg PE, Hirschfeld RM, Petukhova M, Kessler RC: Lifetime and 12-month prevalence of bipolar spectrum disorder in the national comorbidity survey replication. Archives of General Psychiatry 64:543-552, 2007
8. Sadock BJ, Sadock VA: Kaplan & Sadock's Synopsis of Psychiatry, 10th edn. Philadelphia, Lippincott Williams, 2007
9. Peselow ED, Sanfilipo MP, Fieve RR: Relationship between hypomania and personality disorders before and after successful treatment. The American Journal of Psychiatry 152:232-238, 1995
10. Vieta E, Colom F, Martinez-Aran A, Benabarre A, Gasto C: Personality disorders in bipolar II patients. The Journal of Nervous and Mental Disease 187:245-248, 1999
11. Benazzi F: BPD and bipolar II disorder in private practice depressed outpatients. Comprehensive Psychiatry 41:106-110, 2000
12. Heun R, Maier W: Bipolar II disorders in six first-degree relatives. Biological Psychiatry 34:274-276, 1993
13. Torgersen S, Lygren S, Oien PA, Skre I, Onstad S, Edvardsen J, et al.: A twin study of personality disorders. Comprehensive Psychiatry 41:416-425, 2000
14. Strakowski SM, DelBello MP, Zimmerman ME, Getz GE, Mills NP, Ret J, et al.: Ventricular and periventricular structural volumes in first versus multiple-episode bipolar disorder. The American Journal of Psychiatry 159:1841-1847, 2002
15. Lyoo IK, Han MH, Cho DY: A brain MRI study in subjects with borderline personality disorder. Journal of Affective Disorders 50:235-243, 1998
16. Driessen M, Herrmann J, Stahl K, Zwaan M, Meier S, Hill A, et al.: Magnetic resonance imaging volumes of the hippocampus and the amygdala in women with borderline personality disorder and early traumatization. Archives of General Psychiatry 57:1115-1122, 2000
17. Tebartz van Elst L, Hesslinger B, Thiel T, Geiger E, Haegele K, Lemieux L, et al.: Frontolimbic brain abnormalities in patients with borderline personality disorder: A volumetric magnetic resonance imaging study. Biological Psychiatry 54:163-171, 2003
18. Tebartz van Elst L, Ludaescher P, Wilke M, Huppertz HJ, Thiel T, Schmahl C, et al.: A voxel-based morphometric MRI study in female patients with borderline personality disorder. Neuroimage 20:385-392, 2003
19. Schmahl CG, Vermetten E, Elzinga BM, Bremner DJ: Magnetic resonance imaging of hippocampal and amygdala volume in women with childhood abuse and borderline personality disorder. Psychiatry Research 122:193-198, 2003
20. Agrawal HR, Gunderson J, Holmes BM, Lyons-Ruth K: Attachment studies with borderline patients: a review. The Harvard Review of Psychiatry 12:94-104, 2004
21. Zanarini MC: Childhood experiences associated with the development of borderline personality disorder. Psychiatric Clinics of North America 23:89-101, 2000
22. Yen S, Shea MT, Battle CL, Johnson DM, Zlotnick C, Dolan-Sewell R, et al.: Traumatic exposure and posttraumatic stress disorder in borderline, schizotypal, avoidant, and obsessive-compulsive personality disorders: Findings from the collaborative longitudinal personality disorders study. The Journal of Nervous and Mental Disease 190:510-518, 2002
23. Leverich GS, McElroy SL, Suppes T, Keck Jr PE, Denicoff KD, Nolen WA, et al.: Early physical and sexual abuse associated with an adverse course of bipolar illness. Biological Psychiatry 51:288-297, 2002
24. Phelps J: What's the difference between bipolar disorder and "Borderline Personality Disorder"? Psycheducation, 2009. http://www.psycheducation.org/depression/borderline.htm. Accessed 11 Feb 2011
25. Koenisgberg HW, Harvey PD, Mitropolou V, Schmeidler J, New AS, Goodman M, et al.: Characterizing affective instability in borderline personality disorder. The American Journal of Psychiatry 159:784-788, 2002
26. Henry C, Mitropoulou V, New AS, Koenigsberg HW, Silverman J, Siever LJ: Affective instability and impulsivity in borderline personality and bipolar II disorders: Similarities and differences. Journal of Psychiatric Research 35:307-312, 2001
27. Malkoff-Schwartz S, Frank E, Anderson BP, Hlastala SA, Luther JF, Sherrill JT, et al.: Social rhythm disruption and stressful life events in the onset of bipolar and unipolar episodes. Psychological Medicine 30:1005-1016, 2000
28. Wilson ST, Stanley B, Oquendo MA, Goldberg P, Zalsman G, Mann JJ: Comparing impulsiveness, hostility, and depression in borderline personality disorder and Bipolar II disorder. Journal of Clinical Psychiatry 68:1533-1539, 2007
29. Swann AC, Pazzaglia P, Nicholls A, Dougherty DM, Moeller FG: Impulsivity and phase of illness in bipolar disorder. Journal of Affective Disorders 73:1-105, 2003
30. Gunderson JG: Borderline Personality Disorder: A Clinical Guide. Washington DC, American Psychiatric Press, 2001
31. Meyer B, Pilkonis PA, Proietti JM, Heape CL, Egan M: Attachment styles and personality disorders as predictors of symptom course. Journal of Personality Disorders 15:371-389, 2001
32. Benazzi F: A relationship between bipolar II disorder and borderline personality disorder? Progress in Neuro-Psychopharmacology and Biological Psychiatry 32:1022-1029, 2008
33. Abela JR, Payne AV, Moussaly N: Cognitive vulnerability to depression in individuals with borderline personality disorder. Journal of Personality Disorders 17:319-329, 2003
34. Bellodi L, Battaglia M, Gasperini M, Scherillo P, Brancato V: The nature of depression in borderline depressed patients. Comprehensive Psychiatry 33:128-133, 1992
35. Lopez-Larson MP, DelBello MP, Zimmerman ME, Schwiers ML, Strakowski SM: Regional prefrontal gray and white matter abnormalities in bipolar disorder. Biological Psychiatry 52:93-100, 2002
36. Drevets WC, Price JL, Simpson JR Jr, Todd RD, Reich T, Vannier M, et al.: Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386:824-27, 1997
37. Strakowski SM, Delbello MP, Adler CM: The functional neuroanatomy of bipolar disorder: A review of neuroimaging findings. Molecular Psychiatry 10:105-116, 2005
38. Curtis VA, Dixon TA, Morris RG, Bullmore ET, Brammer MJ, Williams SC, et al.: Differential frontal activation in schizophrenia and bipolar illness during verbal fluency. Journal of Affective Disorders 66:111-121, 2001
39. Yurgelun-Todd DA, Gruber SA, Kanayama G, Killgore WD, Baird AA, Young AD: fMRI during affect discrimination in bipolar affective disorder. Bipolar Disorders 2:237-248, 2000
40. Aylward EH, Roberts-Twillie JV, Barta PE, Kumar AJ, Harris GJ, Geer M, et al.: Basal ganglia volumes and white matter hyperintensities in patients with bipolar disorder. The American Journal of Psychiatry 151:687-693, 1994
41. Strakowski SM, DelBello MP, Sax KW, Zimmerman ME, Shear PK, Hawkins JM, et al.: Brain magnetic resonance imaging of structural abnormalities in bipolar disorder. Archives of General Psychiatry 56:254-260, 1999
42. Noga JT, Vladar K, Torrey EF: A volumetric magnetic resonance imaging study of monozygotic twins discordant for bipolar disorder. Psychiatry Research 106:25-34, 2001
43. Altshuler LL, Bartzokis G, Grieder T, Curran J, Jimenez T, Leight K, et al.: An MRI study of temporal lobe structures in men with bipolar disorder and schizophrenia. Biological Psychiatry 48:147-162, 2000
44. Brambilla P, Harenski K, Nicoletti M, Sassi RB, Mallinger AG, Frank E, et al.: MRI investigation of temporal lobe structures in bipolar patients. Journal of Psychiatric Research 37:287-295, 2003
45. DelBello MP, Zimmerman ME, Mills NP, Getz GE, Strakowski SM: Magnetic resonance imaging analysis of amygdala and other subcortical brain regions in adolescents with bipolar disorder. Bipolar Disorders 6:43-52, 2004
46. McCarley RW, Wible CG, Frumin M, Hirayasu Y, Lefitt JJ, Fischer IA, et al.: MRI anatomy of schizophrenia. Biological Psychiatry 45:1099-1119, 1999
47. Strakowski SM, Adler C, DelBello MP: Comparison of morphometric magnetic resonance imaging findings in bipolar disorder and unipolar depression. Bipolar Disorders 4:80-88, 2002
48. Stoll AL, Renshaw PF, Yurgelun-Todd DA, Cohen BM: Neuroimaging in bipolar disorder: What have we learned? Biological Psychiatry 48:505-517, 2000
49. DelBello MP, Strakowski SM, Zimmerman ME, Hawkins JM, Sax KW: MRI analysis of the cerebellum in bipolar disorder: A pilot study. Neuropsychopharmacology 21:63-68, 1999
50. Lippmann S, Manshadi M, Baldwin H, Drasin G, Rice J, Alrajeh S: Cerebellar vermis dimensions on computerized somographic scans of schizophrenic and bipolar patients. The American Journal of Psychiatry 139:667-668, 1982
51. Roy M, Stip E, Black D, Lew V, Langlois R: Cerebellar degeneration following acute lithium intoxication. Revue Neurologique (Paris) 154:546-548, 1998
52. Damasio AR, Tranel D, Damasio H: Individuals with sociopathic behavior caused by frontal damage fail to respond autonomically to social stimuli. Behavioural Brain Research 41:81-94, 1990
53. Rusch N, Luders E, Lieb K, Zahn R, Ebert D, Thompson PM, et al.: Corpus callosum abnormalities in women with borderline personality disorder and comorbid ADHD. Journal of Psychiatry and Neuroscience 32:417-422, 2007
54. Donegan NH, Sanislow CA, Blumberg HP, et al.: Amygdala hyperreactivity in borderline personality disorder: Implications for emotional dysregulation. Biological Psychiatry 54:1284-1293, 2003
55. Brambilla P, Soloff PH, Sala M, et al.: Anatomical MRI study of borderline personality disorder patients. Psychiatry Research 131:125-133, 2004
56. Schmahl CG, Elzinga BM, Vermetten E, et al.: Neural correlates of memories of abandonment in women with and without borderline personality disorder. Biological Psychiatry 54:142-151, 2003
57. Rajkowska G, Halaris A, Selemon LD: Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biological Psychiatry 49:741-752, 2000
58. Ongur D, Drevets WC, Price JL: Glial reduction in the subgenual prefrontal cortex in mood disorders. Proceedings of the National Academy of Sciences of the United States of America 95:13290-13295, 1998
59. Kessler RC, Rubinow DR, Holmes C, Abelson JM, Zhao S: The epidemiology of DSM-III-R bipolar I disorder in a general population survey. Psychological Medicine 27:1079-1089, 1997
60. Heun R, Maier W: The distinction of bipolar II disorder from bipolar I and recurrent unipolar depression: Results of a controlled family study. Acta Psychiatrica Scandinavica 87:279-284, 1993
61. Kieseppa T, Partonen T, Haukka J, Kaprio J, Lonnqvist J: High concordance of bipolar I disorder in a nationwide sample of twins. The American Journal of Psychiatry 161:1814-1821, 2004
62. Barnett JH, Smoller JW: The genetics of bipolar disorder. Neuroscience 164:331-343, 2009
63. Kendler KS, Pedersen NL, Neale MC, Mathe AA: A pilot Swedish twin study of affective illness including hospital-and population-ascertained subsamples: Results of model fitting. Behavior Genetics 25:217-232, 1995
64. McGuffin P, Rijsdijk F, Andrew M, Sham P, Katz R, Cardno A: The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Archives of General Psychiatry 60:497-502, 2003
65. McQueen MB, Devlin B, Faraone SV, Nimgaonkar VL, Sklar P, Smoller JW, et al.: Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and 8q. American Journal of Human Genetics 77:582-595, 2005
66. Reich JH: Familiality of DSM-III dramatic and anxious personality clusters. The Journal of Nervous and Mental Disease 177:96-100, 1989
67. Nigg JT, Goldsmith HH: Genetics of personality disorders: Perspectives from personality and psychopathology research. Psychological Bulletin 115:346-380, 1994
68. Skodol AE, Siever LJ, Livesley WJ, Gunderson JG, Pfohl B, Widiger TA: The borderline diagnosis II: Biology, genetics, and clinical course. Biological Psychiatry 51:951-963, 2002
69. Distel MA, Middeldorp CM, Trull TJ, Derom CA, Willemsen G, Boomsma DI: Life events and borderline personality features: The influence of gene-environment interaction and gene-environment correlation. Psychological Medicine 1:1-12, 2010
70. Zaboli G, Gizatullin R, Nilsonne A, Wilczek A, Jonsson EG, Ahnemark E, Asberg M, Leopardi R: Tryptophan hydroxylase-1 gene variants associate with a group of suicidal borderline women. Neuropsychopharmacology 31:1982-1990, 2006
71. Ni XQ, Chan K, Bulgin N, Sicard T, Bismil R, McMain S, Kennedy JL: Association between serotonin transporter gene and borderline personality disorder. Journal of Psychiatric Research 40:448-453, 2006
72. Joyce PR, Mchugh PC, McKenzie JM, Sullivan PF, Mulder RT, Luty SE, Carter JD, Frampton CM, Robert Cloninger C, Miller AM, Kennedy MA: A dopamine transporter polymorphism is a risk factor for borderline personality disorder in depressed patients. Psychological Medicine 36:807-813, 2006
73. Ni XQ, Sicard T, Bulgin N, Bismil R, Chan K, McMain S, Kennedy JL: Monoamine oxidase A gene is associated with borderline personality disorder. Psychiatric Genetics 17:153-157, 2007
74. Traskman L, Asberg M, Bertilsson L, Sjostrand L: Monoamine metabolites in CSF and suicidal behaviour. Archives of General Psychiatry 38:631-636, 1981
75. Asberg M, Bertillsson L, Martensson B, Scalia-Tomba GP, Thoren P, Traskman-Bendz L: CSF monoamine metabolites in melancholia. Acta Psychiatrica Scandinavica 69:201-219, 1984
76. Shiah IS, Ko HC, Lee JF, Lu RB: Platelet 5-HT and plasma MHPG levels in patients with bipolar I and bipolar II depressions and normal controls. Journal of Affective Disorders 52:101-110, 1999
77. Swann AC, Secunda S, Davis JM, Robins E, Hanin I, Koslow SH, Maas JW: CSF monoamine metabolites in mania. The American Journal of Psychiatry 140:396-400, 1983
78. Cannon DM, Ichise M, Fromm SJ, Nugent AC, Rollis D, Gandhi SK, et al.: Serotonin transporter binding in bipolar disorder assessed using [11C]DASB and positron emission tomography. Biological Psychiatry 60:207-217, 2006
79. Cannon DM, Ichise M, Rollis D, Klaver JM, Gandhi SK, Charney DS, et al.: Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder. Biological Psychiatry 62:870-877, 2007
80. Drevets WC, Frank E, Price JC, Kupfer DJ, Holt D, Greer PJ, et al.: PET imaging of serotonin 1A receptor binding in depression. Biological Psychiatry 46:1375-1387, 1999
81. Drevets WC, Frank E, Price JC, Kupfer DJ, Greer PJ, Mathis C: Serotonin type-1A receptor imaging in depression. Nuclear Medicine and Biology 27:499-507, 2000
82. Drevets WC, Thase ME, Moses-Kolko EL, Price J, Frank E, Kupfer DJ, et al.: Serotonin-1A receptor imaging in recurrent depression: Replication and literature review. Nuclear Medicine and Biology 34:865-877, 2007
83. Nikolaus S, Antke C, Mu ller HW: In vivo imaging of synaptic function in the central nervous system: II. Mental and affective disorders. Behavioural Brain Research 204:32-66, 2009
84. Suhara T, Nakayama K, Inoue O, Fukuda H, Shimizu M, Mori A, et al.: D1 dopamine receptor binding in mood disorders measured by positron emission tomography. Psychopharmacology (Berlin) 106:14-18, 1992
85. Pedro BM, Pilowsky LS, Costa DC, Hemsley DR, Ell PJ, Verhoeff NP, et al.: Stereotypy, schizophrenia and dopamine D2 receptor binding in the basal ganglia. Psychological Medicine 24:423-429, 1994
86. Wong DF, Pearlson GD, Tune LE, Young LT, Meltzer CC, Dannals RF, et al.: Quantification of neuroreceptors in the living human brain: IV. Effect of aging and elevations of D2-like receptors in schizophrenia and bipolar illness. Journal of Cerebral Blood Flow and Metabolism 17:331-342, 1997
87. Alex KD, Pehek EA: Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacology & Therapeutics 113:296-320, 2007
88. Mamelak M: An amphetamine model of manic depressive illness. International Pharmacopsychiatry 13:193-208, 1978
89. van Praag HM, Korf J: Central monoamine deficiency in depressions: Causative of secondary phenomenon? Pharmakopsychiatrie Neuro-Psychopharmakologie 8:322-326, 1975
90. Jacobs D, Silverstone T: Dextroamphetamine-induced arousal in human subjects as a model for mania. Psychological Medicine 16:323-329, 1986
91. Gardner DL, Lucas PB, Cowdry RW: CSF metabolites in borderline personality disorder compared with normal controls. Biological Psychiatry 28:247-254, 1990
92. Koch W, Schaaff N, Popperl G, Mulert C, Juckel G and Reicherzer M, et al.: [I-123] ADAM and SPECT in patients with borderline personality disorder and healthy control subjects. Journal of Psychiatry and Neuroscience 32:234-240, 2007
93. Goodman M, New A, Siever L: Trauma, genes, and the neurobiology of personality disorders. Annals of the New York Academy of Sciences 1032:104-118, 2004
94. Friedel RO: Dopamine dysfunction in borderline personality disorder: A hypothesis. Neuropsychopharmacology 29:1029-1039, 2004
95. Moller HJ, Nasrallah HA: Treatment of bipolar disorder. Journal of Clinical Psychiatry 64:9-17, 2003
96. Goodwin FK: Rationale for long-term treatment of bipolar disorder and evidence for long-term lithium treatment. Journal of Clinical Psychiatry 63:5-12, 2002
97. Suppes T, Dennehy DB: Evidence-based treatment of bipolar II disorder. Journal of Clinical Psychiatry 63:29-33, 2002
98. Links PS, Steiner M, Boiago I, Irwin D: Lithium therapy for borderline patients: Preliminary findings. Journal of Personality Disorders 4:173-181, 1990
99. Evins AE: Efficacy of newer anticonvulsant medications in bipolar spectrum mood disorders. Journal of Clinical Psychiatry 64:9-14, 2003
100. Hadjipavlou G, Mok H, Yatham LN: Pharmacotherapy of bipolar II disorder: A critical review of current evidence. Bipolar Disorders 6:14-25, 2004
101. Cowdry RW, Gardner DL: Pharmacotherapy of borderline personality disorder: Alprazolam, carbamazepine, trifluoperazine, and tranylcypromine. Archives of General Psychiatry 45:111-119, 1988
102. Hollander E, Allen A, Lopez RP, Bienstock CA, Grossman R, Siever LJ, et al.: A preliminary doubleblind, placebo-controlled trial of divalproex sodium in borderline personality disorder. Journal of Clinical Psychiatry 62:199-203, 2001
103. Hollander E, Swann AC, Coccaro EF, Jiang P, Smith TB: Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder. The American Journal of Psychiatry 2005; 162:621-624
104. Zanarini MC, Frankenburg FR, Parachini EA: A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapinefluoxetine combination in women with borderline personality disorder. Journal of Clinical Psychiatry 65:903-907, 2004
105. Zanarini MC, Frankenburg FR: Olanzapine treatment of female borderline personality disorder patients: A double-blind, placebocontrolled pilot study. Journal of Clinical Psychiatry 62:849-854, 2001
106. Bogenschutz MP, Nurnberg GH: Olanzapine versus placebo in the treatment of borderline personality disorder. Journal of Clinical Psychiatry 65:104-119, 2004
107. Hirschfeld RM: The efficacy of atypical antipsychotics in bipolar disorders. Journal of Clinical Psychiatry 64:15-21, 2003
108. Yatham LN: Efficacy of atypical antipsychotics in mood disorders. Journal of Clinical Psychopharmacology 23:S9-S14, 2003
109. Lam DH, Burbeck R, Wright K, Pilling S: Psychological therapies in bipolar disorder: The effect of illness history on relapse prevention-A systematic review. Bipolar Disorders 11:474-482, 2009
110. Lam D, Hayward P, Watkins E, Wright W, Sham P: Outcome of a two-year follow-up of a cognitive therapy of relapse prevention in bipolar disorder. The American Journal of Psychiatry 162:324-329, 2005
111. Ball JR, Mitchell PB, Corry JC, Skillecorn A, Malhi GS: A randomized controlled trial of cognitive therapy from bipolar disorder: Focus on long-term change. Journal of Clinical Psychiatry 67:277-286, 2006
112. Miklowitz DJ, George E, Richards J, Simoneau TL, Suddath R: A randomised study of family-focused psycho-education and pharmacotherapy in the outpatient management of bipolar disorder. Archives of General Psychiatry 60:904-912, 2003
113. Rea MR, Tompson MC, Miklowitz DJ, Goldstein MJ, Hwang S, Mintz J: Family-focused treatment versus individual treatment for bipolar disorder: Results of a randomized clinical trial. Journal of Consulting and Clinical Psychology 71:482-492, 2003
114. Perry A, Tarrier N, Morriss R, McCarthy E, Limb K: Randomised controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment. BMJ 318:139-153, 1999
115. Colom F, Vieta E, Mart?nez-Aran A, et al.: A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission. Archives of General Psychiatry 60:402-407, 2003
116. Colom F, Vieta E, Reinares M, et al.: Psychoeducation efficacy in bipolar disorders: Beyond compliance enhancement. J Clin Psychiatry 64:1101-1105, 2003
117. Binks CA, Fenton M, McCarthy L, et al.: Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev. 1:CD005652, 2006
118. Brazier J, Tumur I, Holmes M, et al.: Psychological therapies including dialectic behaviour therapy for borderline personality disorder: A systematic review and preliminary economic evaluation. Health Technology Assessment 10:1-117, 2006
119. Davidson K, Tyrer P, Gumley A, et al.: A randomized controlled trial of cognitive behavior therapy for borderline personality disorder: Rationale for trial, method and description of sample. Journal of Personality Disorders 20:431-449, 2006
120. Davidson K, Norrie J, Tyrer P, et al.: The effectiveness of cognitive behaviour therapy for borderline personality disorder: Results from the Borderline Personality Disorder Study of Cognitive Therapy (BOSCOT) trial. Journal of Personality Disorders 20:450-465, 2006
121. Palmer S, Davidson K, Tyrer P, et al.: The cost effectiveness of cognitive behavior therapy for borderline personality disorder: Results from the BOSCOT trial. Journal of Personality Disorders 20:466-481, 2006
122. Huband N, McMurran M, Evans C, et al.: Social problem-solving plus psychoeducation for adults with personality disorder. British Journal of Psychiatry 190:307-313, 2007
123. Swann AC, Dougherty DM, Pazzaglia PJ, Pham M, Steinberg JL, Moeller FG: Increased impulsivity associated with severity of suicide attempt history in patients with bipolar disorder. The American Journal of Psychiatry 162:1680-1687, 2005
124. Yen S, Shea MT, Sanislow CA, Grilo CM, Skodol AE, Gunderson JG, et al.: Borderline personality disorder criteria associated with prospectively observed suicidal behavior. The American Journal of Psychiatry 161:1296-1298, 2004
125. Gazalle FK, Andreazza AC, Hallal PC, Kauer-Santanna M, Cereser KM, Soares JC, et al.: Bipolar depression: The importance of being in remission. Revista Brasileira de Psiquiatria 28:93-96, 2006
126. Bauer MS, Kirk GF, GaviN C, Williford WO: Determinants of functional outcome and healthcare costs in bipolar disorder: A high-intensity follow-up study. Journal of Affective Disorders. 65:231-241, 2001
127. Gazalle FK, Hallal PC, Andreazza AC, Frey BN, Kauer-Sant'Anna M, Weyne F, et al.: Manic symptoms and quality of life in bipolar disorder. Psychiatry Res. 153:33-38, 2007
128. Robb JC, Young LT, Cooke RG, Joffe RT: Gender differences in patients with bipolar disorder influence outcome in the medical outcomes survey (SF-20) subscale scores. Journal of Affective Disorders 49:189-193, 1998
129. Gazalle FK, Andreazza AC, Cereser KM, Hallal PC, Santin A, Kapczinski F: Clinical impact of late diagnosis of bipolar disorder. Journal of Affective Disorders 86:313-316, 2005
130. Kauer-Sant'Anna M, Frey BN, Andreazza AC, Cereser KM, Gazalle FK, Tramontina J, et al.: Anxiety comorbidity and quality of life in bipolar disorder patients. Canadian Journal of Psychiatry 52:175-181, 2007
131. Endicott J, Spitzer RL, Fleiss JL, Cohen J: The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Archives of General Psychiatry 33:766-771, 1976
132. Jones SH, Thornicroft G, Coffey M, Dunn G: A brief mental health outcome scale-reliability and validity of the Global Assessment of Functioning (GAF). British Journal of Psychiatry 166:654-659, 1995
133. Piccinni A, Catena M, Del Debbio A, Marazziti D, Monje C, Schiavi E, et al.: Health-related quality of life and functioning in remitted bipolar I outpatients. Comprehensive Psychiatry 48:323-328, 2007
134. Skodol AE, Oldham JM, Bender DS, Dyck IR, Stout RL, Morey LC, et al.: Dimensional representations of DSM-IV personality disorders: Relationships to functional impairment. The American Journal of Psychiatry 162:1919-1925, 2005
135. Mackinnon DF, Pies R: Affective instability as rapid cycling: Theoretical and clinical implications for borderline personality and bipolar spectrum disorders. Bipolar Disorders 8:1-14, 2006
136. Hatchett GT: Differential diagnosis of borderline personality disorder from bipolar disorder. Journal of Mental Health Counseling, 2010. http://findarticles.com/p/articles/mi-hb1416/is-3-32/ai-n54646262/ Accessed 14 Feb 2011
137. Akiskal HS: Subaffective disorders: Dysthymic, cyclothymic, and bipolar II disorders in the "borderline" realm. Psychiatric Clinics of North America 4: 25-46, 1981
138. Gunderson JG, Weinberg I, Daversa MT, Kueppenbender KD, Zanarini MC, Shea MT, et al.: Descriptive and longitudinal observations on the relationship of borderline personality disorder and bipolar disorder. The American Journal of Psychiatry 163:1173-1178, 2006
139. Paris J: Why psychiatrists are reluctant to diagnose: Borderline personality disorder. Psychiatry (Edgmont) 4:35-39, 2007
140. Moreno C, Laje G, Blanco C, Jiang H, Schmidt AB, Olfson M: National trends in the outpatient diagnosis and treatment of bipolar disorder in youth. Archives of General Psychiatry 64:1032-1039, 2007
141. Perugi G, Akiskal HS: The soft bipolar spectrum redefined: Focus on the cyclothymic, anxioussensitive, impulse-dyscontrol, and binge-eating connection in bipolar II and related conditions. Psychiatric Clinics of North America 25:713-737, 2002
142. Vazquez G, Tondo L: ISAD regional meeting 2005. The bipolar spectrum: How far are we going? Journal of Affective Disorders 98:173-175, 2007
143. World Health Organization: International Classification of Mental and Behavioral Disorders. Diagnostic Criteria for Research, 10th edn. Geneva, WHO, 1993
144. Fowler KA, O'Donohue W, Lilienfeld SO: Introduction. In: O'Donohue W, Fowler K, Lilienfeld SO (Eds) Personality Disorders: Toward the DSM-V. Thousand Oaks, CA: Sage, pp. 1-19, 2007